Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study.
about
Update on schizophrenia and bipolar disorder: focus on cariprazineThe International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmDopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases.Cariprazine for Schizophrenia and Bipolar DisorderBrexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazoleEfficacy of Atypical Antipsychotics in the Management of Acute Agitation and Aggression in Hospitalized Patients with Schizophrenia or Bipolar Disorder: Results from a Systematic ReviewTolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials.Mixed states in bipolar disorder - changes in DSM-5 and current treatment recommendations.Is there a 'weight neutral' second-generation antipsychotic for bipolar disorder?Space-Time Cluster Analysis to Detect Innovative Clinical Practices: A Case Study of Aripiprazole in the Department of Veterans Affairs.Cariprazine Exhibits Anxiolytic and Dopamine D3 Receptor-Dependent Antidepressant Effects in the Chronic Stress Model.A New Option for Treating Bipolar I DepressionCariprazine: First Global Approval.Global improvement with cariprazine in the treatment of bipolar I disorder and schizophrenia: A pooled post hoc analysis.The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out.Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
P2860
Q26741533-25518467-F4D5-4E37-9905-83C76D49DA47Q28066714-98CBAB9B-6802-44F8-995F-85F634F61DD4Q28067056-AF732D90-FE0D-4482-A82E-E6D5618A2A69Q28071940-AC192A29-3824-4A0E-9D1E-A66EFFAB280FQ28468613-9F1F24E2-27BD-46BF-889C-CF83F3110B9FQ33695789-D1463851-CDDA-4B75-BD9E-484168CD4FA6Q36109823-F3C07779-9898-4D37-892B-F6DEF8820C2AQ38833165-9B06D2B9-A9B5-479B-9060-A001307A43A2Q39049252-68EB4B9E-401F-4C3A-9506-647246B63E03Q39076017-D0C5B27F-1F4E-412F-8329-B93061239238Q42141320-14159689-88F8-45BE-9AEA-141674E4AB63Q42379554-7B1CCC6C-06C1-4203-870B-0A50867B2B16Q42700276-5A47EAB1-27EB-438C-88B7-9821D118589BQ47627637-8710534D-0768-4BD4-A3B4-2F850FE926D6Q48072363-F35E7104-5E48-4054-A403-2C2F2F028B69Q57483192-55CB7FE9-D893-470C-8AF0-408E76AB368C
P2860
Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Efficacy and safety of low- an ...... ind, placebo-controlled study.
@en
type
label
Efficacy and safety of low- an ...... ind, placebo-controlled study.
@en
prefLabel
Efficacy and safety of low- an ...... ind, placebo-controlled study.
@en
P2093
P356
P1476
Efficacy and safety of low- an ...... ind, placebo-controlled study.
@en
P2093
Anju Starace
György Németh
István Laszlovszky
Joseph R Calabrese
Kaifeng Lu
Paul E Keck
Suresh Durgam
P304
P356
10.4088/JCP.14M09081
P577
2015-03-01T00:00:00Z